COM:ALECTOR
Alector, Inc.
- Stock
name
Alector, Inc. Common Stockhomepage url
www.alector.comcountry
United Statesemployee count
241sector
Healthcareindustry
Biotechnologyrevenue
97.06M
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase ...Show More